title: Controversies in osteoporosis management: how do you treat a newly menopausal woman with low bone mass: when and how is it appropriate to provide pharmacologic intervention to prevent osteoporosis?
authors.affiliation: Departments of *ObGyn ∥Internal Medicine, The Reading Hospital and Medical Center, Reading Departments of †ObGyn ¶Internal Medicine, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania ‡East Bay Physicians Medical Group, Berkeley §Department of ObGyn, University of California, San Francisco, California.
authors.forename: Xuezhi
authors.initials: X
authors.lastname: Jiang
authors.forename: Risa
authors.initials: R
authors.lastname: Kagan
authors.forename: Peter F
authors.initials: PF
authors.lastname: Schnatz
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001851:Bone Diseases, Metabolic / Q000188:drug therapy / Q000503:physiopathology; D003661:Decision Support Techniques; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control*; D058866:Osteoporotic Fractures / Q000209:etiology / Q000517:prevention & control*; D018570:Risk Assessment
chemical_list: D050071:Bone Density Conservation Agents